Amgen Will Develop Predix S1P1 Modulators For Autoimmune Diseases
Amgen will license preclinical S1P1 modulators from Predix for $20 mil. plus additional milestone payments up to $287.5 mil.
Amgen will license preclinical S1P1 modulators from Predix for $20 mil. plus additional milestone payments up to $287.5 mil.